TGY2IT
ABBV icon

Timothy G. Youngquist 2020 Irrevocable Trust’s AbbVie ABBV Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-624
Closed -$136K – 118
2026
Q1 		$136K Buy
+624
New +$138K 0.06% 138

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's ABBV Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 624 shares — an estimated $136K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in ABBV in Q1 2026 and held it in 1 quarter. The position peaked at $136K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 624 AbbVie shares in Q2 2026, an estimated $136K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in AbbVie in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's AbbVie position peaked at $136K in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.